Apelin-13在阿尔茨海默病中的神经保护作用机制研究进展

doi:10.3877/cma.j.issn.2095-655X.2024.04.012

摘要
图/表
参考文献
相关文章 (15)

全文: PDF (443 KB) HTML (1 KB)
输出: BibTeX | EndNote (RIS)

摘要阿尔茨海默病（AD）是目前无法治愈且发病率较高的神经退行性疾病，严重威胁着老年人的生活质量和寿命。据统计，全球范围内AD的患病率逐年上升，且AD发病机制复杂，至今尚无有效的治疗方法。近年研究表明，生物活性肽对AD具有神经保护作用。Apelin-13是一种广泛分布于中枢神经系统神经元和少突胶质细胞的神经肽，参与记忆学习过程和预防神经损伤。研究表明，apelin-13可以直接或间接阻止β淀粉样蛋白的产生、抑制磷酸化Tau蛋白的积累、抗炎、抗凋亡，以及通过调节自噬等减缓AD发生进程。笔者主要对apelin-13在AD中保护作用机制的最新研究进展进行综述，为AD的预防和治疗提供新的思路。

	服务

	把本文推荐给朋友
	加入我的书架
	加入引用管理器
	E-mail Alert
	RSS
	作者相关文章

关键词 ：阿尔茨海默病, Apelin-13, 炎症, 自噬, 凋亡

Abstract：Alzheimer disease (AD) is a currently incurable neurodegenerative disease with a high incidence rate, which seriously threatens the life quality and lifespan of the eldly. According to statistics, the worldwide incidence of AD worldwide is increasing year by year, and the pathogenesis of AD is complex, with no effective treatment method available to date. Recent studies have shown that bioactive peptides have neuroprotective effects on AD. Apelin-13 is an endogenous neuropeptide, which is widely distributed in neurons and oligodendrocytes of the central nervous system, participating in the processes of memory and learning as well as the prevention of neuronal damage. Studies have shown that apelin-13 can directly or indirectly prevent the production of amyloid-β, inhibit the accumulation of phosphorylated Tau protein, exhibit anti-inflammatory and anti-apoptotic effects, as well s modulate autophagy proless, to slow down the progression of AD. The review mainly focuses on the latest research progress on the protective mechanism of apelin-13 in AD, providing new ideas for the prevention and treatment of AD.

Key words： Alzheimer disease Apelin-13 Inflammation Autophagy Apoptosis

收稿日期: 2024-05-23

基金资助:山东省大学生创新训练计划项目(S202210443021，S202410443001,S202410443040）；济宁医学院校级大学生创新训练计划项目（cx2022027z，cx2022129z）

通讯作者: 姜云璐， Email: fcwrjyl@163.com

引用本文:

刘霖张文欢宋雅茹姜云璐. Apelin-13在阿尔茨海默病中的神经保护作用机制研究进展[J]. 中华诊断学电子杂志, 2024, 12(4): 276-280.
Liu Lin1,2, Zhang Wenhuan1,2, Song Yaru1,2, Jiang Yunlu1. . Research advances of the neuroprotective mechanism of apelin-13 in Alzheimer disease. zhzdx, 2024, 12(4): 276-280.

链接本文:

http://www.zhzdxzz.com/CN/10.3877/cma.j.issn.2095-655X.2024.04.012 或 http://www.zhzdxzz.com/CN/Y2024/V12/I4/276

［1］崔慧娟，苏雪，马清清，等.维甲酸类化合物在AD防治中的作用机制研究进展［J］.中华神经医学杂志，2022,21(11)：1184-1188.DOI：10.3760/cma.j.cn115354-20220521-00355. ［2］Scheltens P，De Strooper B，Kivipelto M，et al.Alzheimer′s disease［J］.Lancet，2021,397(10284)：1577-1590.DOI：10.1016/S0140-6736(20)32205-4. ［3］2024 Alzheimer′s disease facts and figures ［J］.Alzheimers Dement，2024,20(5)：3708-3821.DOI：10.1002/alz.13809. ［4］Vaz M，Silvestre S.Alzheimer′s disease：recent treatment strategies［J］.Eur J Pharmacol，2020（887）：173554.DOI：10.1016/j.ejphar.2020.173554. ［5］Wan T，Fu M，Jiang Y，et al.Research progress on mechanism of neuroprotective roles of apelin-13 in prevention and treatment of Alzheimer′s disease［J］.Neurochem Res，2022,47(2)：205-217.DOI：10.1007/s11064-021-03448-1. ［6］Sasaki K，Yamano Y，Bardhan S，et al.Cloning and expression of a complementary DNA encoding a bovine adrenal angiotensin Ⅱ type-1 receptor［J］.Nature，1991,351(6323)：230-233.DOI：10.1038/351230a0. ［7］Fiona AC，Janet JM，David EN，et al.Targeting the apelin system for the treatment of cardiovascular diseases ［J］.Cardiovasc Res，2023,119(17)：2683-2696.DOI：10.1093/cvr/cvad171. ［8］Wei MH，Wu T，Chen N.Bridging neurotrophic factors and bioactive peptides to Alzheimer′s disease ［J］.Ageing Res Rev,2024（94）：102177.DOI：10.1016/j.arr.2023.102177. ［9］Peng QM， Zhou JH， Xu ZW， et al. Apelin-13 ameliorates LPS induced BV-2 microglia inflammatory response through promoting autophagy and inhibiting H3K9ac enrichment of TNF-α and IL-6 promoter ［J］.Acta Neurobiol Exp (Wars),2022，82(1)：65-76.DOI：10.55782/ane-2022-006. ［10］Yoshiya S，Shirabe K，Imai D，et al.Blockade of the apelin-APJ system promotes mouse liver regeneration by activating Kupffer cells after partial hepatectomy［J］.J Gastroenterol，2015,50 (5)：573-582.DOI：10.1007/s00535-014-0992-5. ［11］Chen B，Wu JW，Hu S，et al.Apelin-13 improves cognitive impairment and repairs hippocampal neuronal damage by activating PGC-1α/PPARγ signaling［J］.Neurochem Res，2023,48(5)：1504-1515.DOI：10.1007/s11064-022-03844-1. ［12］Luo HQ，Xiang Y，Qu XP，et al.Apelin-13 suppresses neuroinflammation against cognitive deficit in a streptozotocin-induced rat model of Alzheimer′s disease through activation of BDNF-TrkB signaling pathway［J］.Front Pharmacol，2019（10）：395.DOI：10.3389/fphar.2019.00395. ［13］Luo HQ，Han L，Xu J，et al.Apelin/APJ system：a novel promising target for neurodegenerative diseases［J］.J Cell Physiol，2020,235(2)：638-657.DOI：10.1002/jcp.29001. ［14］Zhou SH，Guo XX，Chen SS，et al.Apelin-13 regulates LPS-induced N9 microglia polarization involving STAT3 signaling pathway［J］.Neuropeptides，2019(76)：101938.DOI：10.1016/j.npep.2019.101938. ［15］Wu S，Chen NJ，Wang CC.Frontiers and hotspots evolution in anti-inflammatory studies for Alzheimer′s disease ［J］.Behav Brain Res,2024(472)：115178.DOI：10.1016/j.bbr.2024.115178. ［16］Reading CL，Ahlem CN，Murphy MF.NM101 phase Ⅲ study of NE3107 in Alzheimer′s disease：rationale，design and therapeutic modulation of neuroinflammation and insulin resistance［J］.Neurodegener Dis Manag，2021，11(4)：289-298.DOI：10.2217/nmt-2021-0022. ［17］Andra LT， Carl WC. Emerging roles of oxidative stress in brain aging and Alzheimer′s disease ［J］.Neurobiol Aging,2021(107)：86-95.DOI：10.1016/j.neurobiolaging. ［18］Zhang P， Yi LH， Meng GY， et al. Apelin-13 attenuates cisplatin-induced cardiotoxicity through inhibition of ROS-mediated DNA damage and regulation of MAPKs and AKT pathways［J］.Free Radic Res，2017,51(5)：449-459.DOI：10.1080/10715762.2017.1313414. ［19］Yildiz Z，Eren N，Orcun A，et al.Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer′s disease［J］.Aging Med (Milton)，2021,4(3)：201-205.DOI：10.1002/ agm2.12173. ［20］Samandari-Bahraseman MR，Elyasi L.Apelin-13 protects human neuroblastoma SH-SY5Y cells against amyloid-beta induced neurotoxicity：involvement of anti oxidant and anti apoptotic properties［J］.J Basic Clin Physiol Pharmacol，2022,33(5)：599-605.DOI：10.1515/jbcpp-2020-0294. ［21］Moriyama M，Moriyama H，Uda J，et al.BNIP3 upregulation via stimulation of ERK and JNK activity is required for the protection of keratinocytes from UVB-induced apoptosis［J］.Cell Death Dis，2017,8(2)：e2576.DOI：10.1038/cddis.2017.4. ［22］Xu RR，Liu YL，Hao M，et al.Apelin-36 alleviates LPS-induced trophoblast cell injury by inhibiting GRP78/ASK1/JNK signaling［J］.Tissue Cell，2023(82)：102057.DOI：10.1016/j.tice.2023.102057. ［23］Salminen A，Kaarniranta K，Kauppinen A，et al.Impaired autophagy and APP processing in Alzheimer′s disease：the potential role of Beclin 1 interactome［J］.Prog Neurobiol，2013(106-107)：33-54.DOI：10.1016/j.pneurobio.2013.06.002. ［24］Gong G，Wan WH，Liu XH，et al.Apelin-13，a regulator of autophagy，apoptosis and inflammation in multifaceted bone protection ［J］.Int Immunopharmacol,2023(117)：109991.DOI：10.1016/j.intimp.2023.109991. ［25］Hou X， Zeng H， Tuo QH， et al. Apelin gene therapy increases autophagy via activation of sirtuin 3 in diabetic heart［J］.Diabetes Res (Fairfax),2015,1(4)：84-91.DOI：10.17140/DROJ-1-115. ［26］Aminyavari S，Zahmatkesh M，Farahmandfar M，et al.Protective role of apelin-13 on amyloid β25-35-induced memory deficit; Involvement of autophagy and apoptosis process［J］.Prog Neuropsychopharmacol Biol Psychiatry,2019(89)：322-334.DOI：10.1016/j.pnpbp.2018.10.005. ［27］Haeberlein SB，Aisen PS，Barkhof F，et al.Two randomized phase 3 studies of aducanumab in early Alzheimer′s disease［J］.J Prev Alzheimers Dis，2022，9(2)：197-210.DOI：10.14283/jpad.2022.30. ［28］Wischik CM， Bentham P， Gauthier S， et al. Oral Tau aggregation inhibitor for Alzheimer′s disease：design，progress and basis for selection of the 16 mg/day dose in a phase 3，randomized，placebo-controlled trial of hydromethylthionine mesylate［J］.J Prev Alzheimers Dis，2022，9(4)：780-790.DOI：10.14283/jpad.2022.63. ［29］Wang C，Liu N，Luan RH，et al.Apelin protects sarcoplasmic reticulum function and cardiac performance in ischaemia-reperfusion by attenuating oxidation of sarcoplasmic reticulum Ca2+-ATPase and ryanodine receptor［J］.Cardiovasc Res，2013，100(1)：114-124.DOI：10.1093/ cvr/cvt160. ［30］Complementary EB，Medicine A.Retracted：regulation of apelin-13 on Bcl-2 and Caspase-3 and its effects on adipocyte apoptosis［J］.Evid Based Complement Alternat Med，2023（2023）：9762535.DOI：10.1155/2023/9762535. ［31］Kurz C，Walker L，Rauchmann BS，et al.Dysfunction of the blood-brain barrier in Alzheimer′s disease：evidence from human studies［J］.Neuropathol Appl Neurobiol，2022,48(3)：e12782.DOI：10.1111/nan.12782. ［32］Cheng J，Luo XL，Huang Z，et al.Apelin/APJ system：a potential therapeutic target for endothelial dysfunction-related diseases［J］.J Cell Physiol，2019,234(8)：12149-12160.DOI：10.1002/jcp.27942. ［33］Hall C，Ehrlich L，Venter J，et al.Inhibition of the apelin/apelin receptor axis decreases cholangiocarcinoma growth［J］.Cancer Lett，2017(386)：179-188.DOI：10.1016/j.canlet.2016.11.025. ［34］Chu HL，Yang XB，Huang CY，et al.Apelin-13 protects against ischemic blood-brain barrier damage through the effects of aquaporin-4［J］.Cerebrovasc Dis，2017,44(1/2)：10-25.DOI：10.1159/000460261. ［35］Yildiz Z,Eren N,Orcun A，et al.Serum apelin-13 levels and total oxidant/antioxidant status of patients with Alzheimer′s disease［J］.Aging Med (Milton)，2021,4(3)：201-205.DOI：10.1002/agm2.12173. ［36］Acikel SB,Artik A,Hosoglu E，et al.Serum apelin-13 levels are decreased among adolescents diagnosed with major depressive disorder［J］.Psychiatr Danub,2022,34(4)：677-681.DOI：10.24869/psyd.2022.677.